131 related articles for article (PubMed ID: 19126665)
1. Chronic angiotensin-converting enzyme inhibition up-regulates mouse kidney growth arrest specific-6 protein and the AXL subfamily of receptor tyrosine kinases.
Eng PC; Chua WC; Suk Peng Chew V; Wong PT; Yin JL; Hambly B; McLachlan CS
J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):238-41. PubMed ID: 19126665
[TBL] [Abstract][Full Text] [Related]
2. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
Fiebeler A; Park JK; Muller DN; Lindschau C; Mengel M; Merkel S; Banas B; Luft FC; Haller H
Am J Kidney Dis; 2004 Feb; 43(2):286-95. PubMed ID: 14750094
[TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
[TBL] [Abstract][Full Text] [Related]
5. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
Bernátová I; Pechánová O; Simko F
Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
[TBL] [Abstract][Full Text] [Related]
6. Expression of growth arrest-specific gene 6 and its receptors in dysfunctional human renal allografts.
Yin JL; Hambly BD; Bao SS; Painter D; Bishop GA; Eris JM
Transpl Int; 2003 Sep; 16(9):681-8. PubMed ID: 12768229
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
9. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases.
Nagata K; Ohashi K; Nakano T; Arita H; Zong C; Hanafusa H; Mizuno K
J Biol Chem; 1996 Nov; 271(47):30022-7. PubMed ID: 8939948
[TBL] [Abstract][Full Text] [Related]
10. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
[TBL] [Abstract][Full Text] [Related]
12. Role of Axl in target organ inflammation and damage due to hypertensive aortic remodeling.
Chen W; Van Beusecum JP; Xiao L; Patrick DM; Ao M; Zhao S; Lopez MG; Billings FT; Cavinato C; Caulk AW; Humphrey JD; Harrison DG
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H917-H933. PubMed ID: 36083796
[TBL] [Abstract][Full Text] [Related]
13. Identification and regulation of receptor tyrosine kinases Rse and Mer and their ligand Gas6 in testicular somatic cells.
Chan MC; Mather JP; McCray G; Lee WM
J Androl; 2000; 21(2):291-302. PubMed ID: 10714824
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor expression in glomeruli from NO-deficient rats.
Vandermeersch S; Stefanovic V; Hus-Citharel A; Ardaillou R; Dussaule JC; Chansel D
Nephron Exp Nephrol; 2003; 95(3):e119-28. PubMed ID: 14646364
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system.
Prieto AL; Weber JL; Lai C
J Comp Neurol; 2000 Sep; 425(2):295-314. PubMed ID: 10954847
[TBL] [Abstract][Full Text] [Related]
17. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
Seth MK; Hussain ME; Pasha S; Fahim M
Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
[TBL] [Abstract][Full Text] [Related]
18. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
Hafizi S; Dahlbäck B
Cytokine Growth Factor Rev; 2006 Aug; 17(4):295-304. PubMed ID: 16737840
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.
Nagai K; Arai H; Yanagita M; Matsubara T; Kanamori H; Nakano T; Iehara N; Fukatsu A; Kita T; Doi T
J Biol Chem; 2003 May; 278(20):18229-34. PubMed ID: 12644472
[TBL] [Abstract][Full Text] [Related]
20. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Landolt L; Furriol J; Babickova J; Ahmed L; Eikrem Ø; Skogstrand T; Scherer A; Suliman S; Leh S; Lorens JB; Gausdal G; Marti HP; Osman T
Physiol Rep; 2019 May; 7(10):e14091. PubMed ID: 31134766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
